Invention Grant
- Patent Title: Tetrandrine family pharmaceutical formulations and method
-
Application No.: US15346022Application Date: 2016-11-08
-
Publication No.: US10023584B2Publication Date: 2018-07-17
- Inventor: Ron D. Carroll
- Applicant: CBA Pharma, Inc.
- Applicant Address: US KY Lexington
- Assignee: CBA Pharma, Inc.
- Current Assignee: CBA Pharma, Inc.
- Current Assignee Address: US KY Lexington
- Agency: Mitchell Intellectual Property Law, PLLC
- Main IPC: A61K31/4748
- IPC: A61K31/4748 ; C07D491/147 ; A61K45/06 ; A61K31/4741 ; A61K9/48
Abstract:
Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially d-tetrandrine di-hydrochloride, combined with a pharmaceutical diluent or carrier.
Public/Granted literature
- US20170050975A1 TETRANDRINE FAMILY PHARMACEUTICAL FORMULATIONS AND METHOD Public/Granted day:2017-02-23
Information query
IPC分类:
